Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 11/06/2025 | Q3 | -- | $15.9B | $71.68 | -- | -- |
| 07/31/2025 | Q2 | -- | $16B | $85.26 | -- | -- |
| 05/01/2025 | Q1 | $10.9B | $16.1B | $61.27 | $37.28 | $23.98 |
| 02/13/2025 | Q4 | -- | $14.4B | $70.51 | $55.20 | $15.31 |
| 10/31/2024 | Q3 | -- | $15.9B | $58.13 | $33.29 | $24.85 |
| 08/01/2024 | Q2 | -- | $13.5B | $50.87 | $40.44 | $10.43 |
| 05/02/2024 | Q1 | -- | $13.1B | $41.56 | $41.99 | -$0.42 |
| 02/15/2024 | Q4 | -- | $14.1B | $72.01 | $28.95 | $43.06 |
| 11/02/2023 | Q3 | -- | $12.6B | $56.68 | -- | -- |
| 08/03/2023 | Q2 | -- | $11.2B | $38.68 | -- | -- |
| 05/11/2023 | Q1 | -- | $12.1B | $66.79 | -- | -- |
| 02/16/2023 | Q4 | -- | $12.3B | $124.72 | -- | -- |
| 11/03/2022 | Q3 | -- | $10.6B | $25.22 | -- | -- |
| 07/28/2022 | Q2 | -- | $9.3B | -$1.72 | -- | -- |
| 04/28/2022 | Q1 | -- | $9.1B | $28.71 | -- | -- |
| 02/10/2022 | Q4 | -- | $8.5B | $42.41 | -- | -- |
| 11/04/2021 | Q3 | -- | $7.9B | $20.71 | -- | -- |
| 07/29/2021 | Q2 | -- | $8.1B | $53.10 | -- | -- |
| 04/29/2021 | Q1 | -- | $7.4B | $36.61 | -- | -- |
| 02/11/2021 | Q4 | -- | $8.6B | $42.58 | -- | -- |
| 10/29/2020 | Q3 | -- | $6.6B | $5.92 | -- | -- |
| 07/30/2020 | Q2 | -- | $7.1B | $21.14 | -- | -- |
| 04/30/2020 | Q1 | -- | $4.4B | -$63.73 | -- | -- |
| 02/13/2020 | Q4 | -- | $7.6B | $31.13 | -- | -- |
| 10/31/2019 | Q3 | -- | $6.3B | $2.69 | -- | -- |
| 08/01/2019 | Q2 | -- | $6.8B | $22.99 | -- | -- |
| 05/02/2019 | Q1 | -- | $7.3B | $35.87 | -- | -- |
| 02/14/2019 | Q4 | -- | $5.3B | -$23.42 | -- | -- |
| 11/01/2018 | Q3 | -- | $5.7B | $4.37 | -- | -- |
| 08/03/2018 | Q2 | -- | $5.4B | $2.36 | -- | -- |
| 05/03/2018 | Q1 | -- | $5.1B | $29.85 | -- | -- |
| 02/15/2018 | Q4 | -- | $5.4B | $38.21 | -- | -- |
| 11/03/2017 | Q3 | -- | $4.9B | $20.58 | -- | -- |
| 08/03/2017 | Q2 | -- | $4.3B | $17.03 | -- | -- |
| 04/27/2017 | Q1 | -- | $3.6B | $4.01 | -- | -- |
| 02/17/2017 | Q4 | -- | $2.4B | -$41.06 | -- | -- |
| 11/04/2016 | Q3 | -- | $3.1B | -$0.55 | -- | -- |
| 06/30/2016 | Q2 | -- | $3.7B | $12.34 | -- | -- |
| 03/31/2016 | Q1 | -- | $3B | -$3.79 | -- | -- |
| 12/31/2015 | Q4 | -- | $3.6B | $5.47 | -- | -- |
Fairfax Financial Holdings Ltd. reported $15.9B worth of top line sales in its most recent quarter.
Fairfax Financial Holdings Ltd. announced earnings per share of $71.68 which represents a beat of analyst forecast a -- per share.
Fairfax Financial Holdings Ltd. reported -- that represents -- per share over the last quarter.
Fairfax Financial Holdings Ltd.'s earnings are forecast to grow from $219.97 per share to $168.11 per share next year representing an increase of 0.92%.
Fairfax Financial Holdings Ltd.'s next earnings date is February 12, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.